Qianben Wang Laboratory: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
No edit summary
(12 intermediate revisions by the same user not shown)
Line 1: Line 1:
<div style="padding: 20px; color: #ffffff; background-color: mediumblue; width: 900px">
<div style="padding: 20px; color: #ffffff; background-color: mediumBlue; width: 900px">
<center><font face="lucida fax" style= "color:Crimson" size="+10">'''Qianben Wang Laboratory'''</font>
<center><font face="lucida fax" style= "color:Yellow" size="+10">'''Qianben Wang Laboratory'''</font>
</center>
</center>
<br>
<br>
<center><font face="lucida fax" style= "color:Crimson" size="+2">'''Laboratory of Cancer Epigenomics'''</font></center>
<center><font face="lucida fax" style= "color:Yellow" size="+2">'''Laboratory of Cancer Epigenomics'''</font></center>
<br>
<br>
<center><font face="lucida fax" style= "color:Crimson" size="+1">'''Department of Molecular and Cellular Biochemistry, The Ohio State University'''</font>
<center><font face="lucida fax" style= "color:Yellow" size="+1">'''Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University'''</font>
<br>
<br>
[[Wang | <font face="lucida fax" style="color:#ffffff" size="+1"> '''Home''' </font>]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
[[Wang | <font face="lucida fax" style="color:#ffffff" size="+1"> '''Home''' </font>]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Line 18: Line 18:
<table border="4" color="mediumblue">
<table border="4" color="mediumblue">
<td width="926">
<td width="926">
[[Image:Wanglab 7.12.10 500px IMG 0018.jpg|right]] [[Image:DOD 2 FigurebyZhong.jpg]]
[[Image:exo.tif]]
<div style="text-align:left" font face="lucia fax">'''A histone modification governs androgen receptor to bind to regulatory regions of a class of cell cycle genes in castration-resistant prostate cancer but not in androgen-dependent prostate cancer. This leads to over-expression of cell cycle genes and accelerated growth of castration resistant prostate cancer.  
<div style="text-align:left" font face="lucia fax">'''The schematic diagram of androgen receptor binding element (ARBE)-directed AR transcriptional regulation. Upper panel shows that agonist-bound AR (red) recognizes an agonist-ARBE in an agonist-specific manner, whereas the bottom panel indicates that antagonist-bound AR (blue) binds to an antagonist-ARBE in an antagonist-dependent manner. The binding of AR to two distinctly different motifs leads to distinct transcriptional outcomes in prostate cancer. The crystal structures of the DNA binding domain (DBD), dihydrotestosterone-ligand binding domain (DHT-LBD) and bicalutamide-LBD are modified from 1R4I, 1T7T and 1Z95, respectively.  
</div>
</div>


</td>
</td>
</table>
</table>

Revision as of 14:11, 23 December 2014

Qianben Wang Laboratory


Laboratory of Cancer Epigenomics


Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University


Home              Research              Publications              Lab Members              Contact              News              Gallery

The schematic diagram of androgen receptor binding element (ARBE)-directed AR transcriptional regulation. Upper panel shows that agonist-bound AR (red) recognizes an agonist-ARBE in an agonist-specific manner, whereas the bottom panel indicates that antagonist-bound AR (blue) binds to an antagonist-ARBE in an antagonist-dependent manner. The binding of AR to two distinctly different motifs leads to distinct transcriptional outcomes in prostate cancer. The crystal structures of the DNA binding domain (DBD), dihydrotestosterone-ligand binding domain (DHT-LBD) and bicalutamide-LBD are modified from 1R4I, 1T7T and 1Z95, respectively.